Trade Summary

6 months ago, Traversa Sergio, serving as CEO at Relmada Therapeutics, Inc. (RLMD), purchased 272,500 shares at $2.20 per share, for a total transaction value of $599,500.00. Following this transaction, Traversa Sergio now holds 1,272,500 shares of RLMD.

This purchase represents a 27.00% increase in Traversa Sergio's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, November 5, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, November 6, 2025 at 2:30 AM ET, 1 day after the trade was made.

Relmada Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.